These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12875342)
1. Clinical trials in Russia and Eastern Europe: recruitment and quality. Platonov P Int J Clin Pharmacol Ther; 2003 Jul; 41(7):277-80. PubMed ID: 12875342 [TBL] [Abstract][Full Text] [Related]
4. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506 [TBL] [Abstract][Full Text] [Related]
5. When to conduct a clinical trial. Boutrand JP Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271 [TBL] [Abstract][Full Text] [Related]
6. Successful recruitment for medical device clinical studies. Donawa M Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270 [TBL] [Abstract][Full Text] [Related]
7. Afterword: five steps to increase the payoff of chronic pain trials. Max MB Neurology; 2005 Dec; 65(12 Suppl 4):S74-7. PubMed ID: 16385108 [No Abstract] [Full Text] [Related]
8. Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. Li J; Gao W; Punja S; Ma B; Vohra S; Duan N; Gabler N; Yang K; Kravitz RL J Clin Epidemiol; 2016 Aug; 76():57-64. PubMed ID: 26769257 [TBL] [Abstract][Full Text] [Related]
9. Family medicine in post-communist Europe needs a boost. Exploring the position of family medicine in healthcare systems of Central and Eastern Europe and Russia. Oleszczyk M; Svab I; Seifert B; Krztoń-Królewiecka A; Windak A BMC Fam Pract; 2012 Mar; 13():15. PubMed ID: 22409775 [TBL] [Abstract][Full Text] [Related]
10. Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop. Khin NA; Francis G; Mulinde J; Grandinetti C; Skeete R; Yu B; Ayalew K; Cho SJ; Fisher A; Kleppinger C; Ayala R; Bonapace C; Dasgupta A; Kronstein PD; Vinter S Clin Pharmacol Ther; 2020 Nov; 108(5):949-963. PubMed ID: 31958142 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials integrity: a CRO perspective. Beach JE Account Res; 2001; 8(3):245-60. PubMed ID: 12481762 [TBL] [Abstract][Full Text] [Related]
12. Next steps in clinical trial redesign. Nicholas J J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851 [No Abstract] [Full Text] [Related]
13. Interview with Gary L. Yingling, J.D. Yingling GL Qual Manag Health Care; 1999; 7(3):45-7. PubMed ID: 10537462 [No Abstract] [Full Text] [Related]
14. Time to adapt. Nature; 2010 Apr; 464(7293):1245-6. PubMed ID: 20428115 [No Abstract] [Full Text] [Related]
15. Continuous quality improvement in contract research organizations--the customer focus. Sollecito WA; Kaluzny AD Qual Manag Health Care; 1999; 7(3):7-21. PubMed ID: 10537463 [TBL] [Abstract][Full Text] [Related]
16. Current situation of clinical trials in Beijing and Shanghai, China. Yoshida Y; Xue D; Yoshida Y; Zhang Y; Ma D; Sato Y; Wang P Int J Clin Pharmacol Ther; 2013 May; 51(5):433-40. PubMed ID: 23547853 [TBL] [Abstract][Full Text] [Related]
19. Health status, health problems and practices among refugees from the Middle East, Eastern Europe and Southeast Asia. Young RF; Bukoff A; Waller Jb ; Blount SB Int Migr Rev; 1987; 21(3):760-82. PubMed ID: 12314904 [TBL] [Abstract][Full Text] [Related]
20. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Huang SM; Temple R; Throckmorton DC; Lesko LJ Clin Pharmacol Ther; 2007 Feb; 81(2):298-304. PubMed ID: 17259955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]